ELIXADA

Live / Registered — Registered (as of 06 Jul 2021)

What this means for you

Registered since 06 Jul 2021. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
88902639
Registration number
6406637
Mark type
Stylized text
Filed
06 May 2020
Published for opposition
20 Apr 2021
Registered
06 Jul 2021
Attorney of record
Scott D. Woldow

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia in the nature of pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders

Owner

Prosecution history

  • 06 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
  • 20 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 20 Apr 2021 — PUBLISHED FOR OPPOSITION
  • 31 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 17 Mar 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 15 Mar 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 15 Mar 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 15 Mar 2021 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
  • 01 Mar 2021 — NOTIFICATION OF FINAL REFUSAL EMAILED
  • 01 Mar 2021 — FINAL REFUSAL E-MAILED
  • 01 Mar 2021 — FINAL REFUSAL WRITTEN
  • 27 Jan 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 27 Jan 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 27 Jan 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 08 Aug 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED

View this trademark record on Marksy